Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (9452)	3/30/1999 1:40:00 PM
From: aknahow	Respond to of 17367

NEW NON NOVEL United States Patent 5,888,973 Lambert, Jr. Mar. 30, 1999 Anti-chlamydial uses of BPI protein products Abstract The present invention relates to methods for treating chlamydial infection comprising administering to a subject suffering from a chlamydial infection a bactericidal/permeability-inducing (BPI) protein product. Since XOMA has said nothing about this patent I can only assume it is not novel and is of litle value. Still with 30% of sexually active teenagers having this disease one would think it might be of some slight use. I estimate at least 30% of teenagers are sexually active.